Designing Chimeric Molecules for Drug Discovery by Leveraging Chemical Biology.

Designing Chimeric Molecules for Drug Discovery by Leveraging Chemical Biology.

Borsari, Chiara;Trader, Darci J;Tait, Annalisa;Costi, Maria Paola;
Journal of medicinal chemistry 2020
197
borsari2020designingjournal

Abstract

After the first seed concept introduced in the 18th century, different disciplines have attributed different names to dual-functional molecules depending on their application, including bioconjugates, bifunctional compounds, multi targeting molecules, chimeras, hybrids, engineered compounds. However, these engineered constructs share a general structure: a first component which targets a specific cell and a second component that exerts the pharmacological activity. A stable or cleavable linker connects the two modules of a chimera. Herein, we discuss the recent advances in the rapidly expanding field of chimeric molecules leveraging chemical biology concepts. This perspective is focused on bifunctional compounds in which one component is a lead compound or a drug. In details, we discuss chemical features of chimeric molecules, their use for targeted delivery, and for target engagement studies.

Citation

ID: 92794
Ref Key: borsari2020designingjournal
Use this key to autocite in SciMatic or Thesis Manager

References

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
92794
Unique Identifier:
10.1021/acs.jmedchem.9b01456
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet

Saymatik Web3.0 Wallet